Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Thomas B. Wiltbank"'
Autor:
Thomas B. Wiltbank, Marjorie Bravo, Peter Tomasulo, Hany Kamel, Robert C. James, Brian Custer, Robin Cusick
Publikováno v:
Transfusion. 50:556-565
BACKGROUND: Blood donation is safe, but a small proportion of donors have delayed and/or off-site reactions that have the potential to lead to serious injury. This retrospective study sought to identify risk factors for delayed reactions (DRs). STUDY
Autor:
Hany Kamel, Gerald F. Giordano, Peter Tomasulo, Brian Custer, Thomas B. Wiltbank, Marjorie Bravo
Publikováno v:
ISBT Science Series. 4:143-153
Background A small proportion of blood donors have adverse reactions. The purpose of this study was to determine predictors of faint and significant hypotensive reactions that could serve as targets for interventions to reduce reactions, thus improvi
Publikováno v:
Transfusion. 48:1799-1808
BACKGROUND: A small proportion of blood donors have adverse reactions. The purpose of this study was to determine predictors of faint and significant hypotensive reactions that could serve as targets for interventions to reduce reactions, thus improv
Autor:
Gerald F. Giordano, Thomas B. Wiltbank
Publikováno v:
Transfusion. 47:1002-1005
BACKGROUND: Recent technology allows for the collection of 2-unit red cells (RBCs) and single-unit RBCs plus plasma or platelets (PLTs). STUDY DESIGN AND METHODS: With a common definition of adverse events, 1,023,682 whole-blood collections were eval
Autor:
Brian Custer, Hany Kamel, Steven H. Kleinman, Thomas B. Wiltbank, Kim-Anh Nguyen, Sandra Vanderpool, Peter Tomasulo, Dennis Harpool
Publikováno v:
Transfusion. 46:1787-1794
BACKGROUND: Throughout its system of regional centers, Blood Systems implemented culture based bacterial testing with a standardized protocol for both apheresis and whole blood–derived platelets (PLTs). STUDY DESIGN AND METHODS: After a 24-hour hol
Autor:
Thomas B, Wiltbank, Gerald F, Giordano
Publikováno v:
Transfusion. 47(6)
Recent technology allows for the collection of 2-unit red cells (RBCs) and single-unit RBCs plus plasma or platelets (PLTs).With a common definition of adverse events, 1,023,682 whole-blood collections were evaluated and compared with 249,154 two-uni
Autor:
Donald S. Israel, Kirk Kitchen, Sergio Torloni, Thomas B. Wiltbank, Stephen Hunt, Federico Rodriguez
Publikováno v:
Blood. 108:5228-5228
Background: Peripheral Blood Progenitor Cells (PBPC) cryopreserved in DMSO are thawed at the patient’s bedside and infused immediately. Usually the infusions are completed without incident. There are occasions when mild/severe transfusion related r
Publikováno v:
Blood. 104:836-836
Bacterial contamination has represented the second leading cause for transfusion- associated mortality. The French hemovigilance study indicated that in neutropenic and immune depressed patients the mortality is almost 100%. With the approval of two
Publikováno v:
Transfusion. 27(1)
Two commercially available enzyme-linked immunosorbent assays (ELISA) were compared in screening a large population of volunteer blood donors. One ELISA utilized the human T-lymphotropic virus, Type III (HTLV-III) grown on National Institutes of Heal
Autor:
Thomas B. Wiltbank
Publikováno v:
JAMA: The Journal of the American Medical Association. 229:340
The overleaf of this monograph suggests "that there is no hematology textbook, cytology atlas or monograph which deals exclusively with a comprehensive, standardized system of marrow biopsy technique." The publisher therefore suggests that this parti